Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study to Evaluate the Efficacy and Safety of 9% Dexamethasone Intraocular Injection for the Treatment of Inflammation Associated With Cataract Surgery

NCT06497699 is registered in ClinicalTrials.gov with Ocumension Therapeutics (Shanghai) Co., Ltd as lead sponsor.

NCT NCT06497699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06497699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study to Evaluate the Efficacy and Safety of 9% Dexamethasone Intraocular Injection for the Treatment of Inflammation Associated With Cataract Surgery
Lead sponsor
Ocumension Therapeutics (Shanghai) Co., Ltd
Phase
Phase 4
Overall status
Completed
Start date
October 28, 2021
Completion date
December 14, 2023
Enrollment
263 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cataract, inflammation